Curaleaf Holdings (CURLF) Interest & Investment Income (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Interest & Investment Income of $212000.0 for Q1 2026, up 23.98% year-over-year from $171000.0 in Q1 2025, and up 21.84% quarter-over-quarter from $174000.0 in Q4 2025.
Curaleaf Holdings (CURLF) Interest & Investment Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $212000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 23.98% year-over-year to $212000.0; the TTM figure through Mar 2026 stood at $703000.0 (down 24.41% YoY), while the FY2025 annual figure was $663000.0, down 14.56% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $212000.0, up from $174000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $310000.0 in Q2 2024, with the low at $1000.0 in Q2 2023.
- The 5-year median for Interest & Investment Income is $166000.0 (2025), against an average of $133000.0.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income tumbled 96.4% in 2022, then surged 30900.0% in 2024.
- Curaleaf Holdings' Interest & Investment Income stood at $36000.0 in 2022, then sank by 97.22% to $1000.0 in 2023, then soared by 17400.0% to $175000.0 in 2024, then slipped by 0.57% to $174000.0 in 2025, then climbed by 21.84% to $212000.0 in 2026.
- Business Quant data shows CURLF's Interest & Investment Income at $212000.0 in Q1 2026, $174000.0 in Q4 2025, and $151000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | 149,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 149,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 174,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 310,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 129,000.00 |
| Jun 30, 2021 | 278,000.00 |
| Mar 31, 2021 | 88,000.00 |
| Dec 31, 2020 | 24,000.00 |
| Sep 30, 2020 | 40,000.00 |